The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Experimental research

The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model

EuroIntervention 2005;1:228-235 - DOI10.4244/EIJV1I2A37.

1. Cardiovascular Intervention Center, Cedars Sinai Medical Center Los Angeles Ca, USA; 2. Biomedical Research Foundation of South Texas, San Antonio, Tx, USA; 3. Conor MedSystems, Menlo Park Ca, USA; 4. Erasmus Medical Center, Rotterdam, The Netherlands

Aims: Paclitaxel is a potent and effective inhibitor of neointimal proliferation after coronary stenting. The Conor stent loaded with Paclitaxel can be programmed with multi-parameter matri

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Inhibition of intimal hyperplasia by the tetracycline derived MMP inhibitor doxycycline in vein graft disease in vitro and in vivo